REGENEREX PHARMA, INC. 8-K
Research Summary
AI-generated summary
Regenerex Pharma Files Suit Against Former CFO's Company
What Happened
Regenerex Pharma, Inc. announced on June 22, 2026 (via an 8-K and a litigation update dated June 15, 2026) that it commenced legal proceedings against Optimize Health Partners, LLC — a Delaware LLC doing business in Tennessee and owned by the company's former CFO, Kenneth W. Perry. The action, filed in Smith County Chancery Court as Case No. 2026-CV-8819, seeks recovery of funds and other relief related to conduct during Mr. Perry’s tenure. The company is pursuing monetary damages, restitution, disgorgement where applicable, injunctive relief, costs and other remedies; the defendant has denied the material allegations and intends to defend the case.
Key Details
- Defendant: Optimize Health Partners, LLC (owned by former CFO Kenneth W. Perry).
- Court & Case No.: Smith County Chancery Court, Case No. 2026-CV-8819.
- Date: Litigation update referenced June 15, 2026; 8-K filed June 22, 2026.
- Relief sought: Monetary damages, restitution, disgorgement, injunctive relief, costs; outcome is not assured and allegations remain subject to judicial determination.
Why It Matters
This is a legal matter involving the company and its former CFO’s business that could affect Regenerex’s finances, management reputation, and resources depending on the outcome. Investors should note the allegations are contested, the litigation is in early stages, and the company has signaled it will pursue the claims vigorously. Monitor future filings for developments, potential financial exposure, or settlement information.